Many patients with interleukin 28B genotypes associated with response to therapy are ineligible for treatment because of comorbidities.

F. Kanwal,D. White,S. Tavakoli-Tabasi,L. Jiao,D. Lin,D. Ramsey,Andrew Spiegelman,Jill Kuzniarek,H. El‐Serag
DOI: https://doi.org/10.1016/j.cgh.2013.08.034
IF: 13.576
2014-02-01
Clinical Gastroenterology and Hepatology
Abstract:
What problem does this paper attempt to address?